By analyzing the tumor microenvironment, we could observe that IBCs with PIWIL2 underexpression were significantly correlated with increased immune cytotoxic CD8+ response, suggesting that PIWIL2 could constitute a pertinent predictive biomarker of sensitivity to immunotherapies. Here, CD8A is linked to neoplasm.